Skip to Content

Alzheimer's: Revolutionizing Diagnosis and Treatment

A new diagnostic tool, called amyloid imaging, which uses an FDA-approved agent called Amyvid to bind to abnormal proteins in the brain, is allowing physicians, for the first time ever, to diagnose Alzheimer's Disease definitively. This screening tool could also provide researchers with the insight they need to one day prevent Alzheimer's Disease.

It is generally accepted that treatments for Alzheimer's Disease, the seventh leading cause of death in the U.S., will be much more effective if introduced prior to the onset of symptoms and before significant brain destruction occurs. However, until now researchers could not study treatments to prevent Alzheimer's Disease because they had no way of knowing who would develop it.

Learn more about Amyloid Imaging and how it works in the video below:

Views or opinions presented in this video are solely those of the physician(s) or presenter(s) and do not necessarily represent the views and opinions of Memorial Hermann Health System. This video is presented to the public for educational purposes only and Memorial Hermann Health System is not responsible for its content. Patients should consult a physician regarding the diagnosis and treatment of any medical condition.

Learn more about the future medications being developed to treat Alzheimer's at the Alzheimer's Association web site.